Page 183 - Read Online
P. 183

Page 2 of 8                                     Hu et al. J Cancer Metastasis Treat 2018;4:39  I  http://dx.doi.org/10.20517/2394-4722.2018.08

                                                                        Gastric wall














                                                       Cancer cells



                                                                                   Peritoneum





                                   Figure 1. The metastatic cascade of peritoneal dissemination in gastric cancer

               Table 1. The major molecules involved in development of peritoneal dissemination in gastric cancer
                                       Molecule      Biological function  Associated molecules/  References
                                                                            pathways
                Detachment from the    E-cadherin   Cell-cell adhesion  Wnt, Rho GTPase, NF-κB   [14-19]
                primary tumor                                          pathway, EMT
                                       ARL4C        GTP-binding protein  Rho GTPase, EGF, Wnt  [23,24]
                Adaptation to the peritoneal   HIF1α  Regulation of cellular and   EMT, NF-κB pathway,   [39-42]
                cavity microenvironment             systemic homeostatic   Glucose metabolism
                                                    responses to hypoxia
                                       LOX          Lysyl oxidase      EMT                    [43]
                                       ANGPTL4      Resistance to anoikis  FAK/Src/PI3K/Akt/ERK  [46]
                                       CXCL12       Chemokine ligand   EMT, CXCL12/CXCR4      [55,56]
                                       Akt          Serine-threonine kinase  PI3K/Akt, PTEN/PI3K/  [50-54]
                                                                       NF-κB/FAK
                                       FAK          Tyrosine kinase    Fak/Src                [53,54]
                Attachment toperitoneal   Integrin a3b1  Cell adhesion  Lamine-5              [63]
                mesothelial cells and tumor   VEGF  Vascular endothelial   Angiogenesis       [61,65-67]
                growth                              growth factor


               molecular mechanisms of PD is important for developing novel therapies and improving the clinical
               outcomes of GC patients.

               The metastatic cascade of GC consists of lymphatic metastasis, hematogenous metastasis, and PD. Although
               the lymphatic metastasis and hematogenous metastasis are the major dissemination processes in solid
               cancers, PD is the most frequent metastatic type in GC patients, according to the annual report 2009 from
               Japanese Gastric Cancer Association. Unlike the lymphatic metastasis and the hematogenous metastasis,
               the peritoneal dissemination is initially driven by direct invasion from gastric wall to the peritoneal cavity.

               Many metastasis-related factors, such as adhesion molecules, matrix proteases, and motility factors, are
               involved in the development of PD, which is a multistep process . The first step involves detachment
                                                                        [5-9]
               of cancer cells from the primary tumor, followed by survival of the cells in the microenvironment of the
               peritoneal cavity. The last step is attachment of circulating tumor cells to peritoneal mesothelial cells and
               tumor growth. In this review, we highlight the major molecular mechanisms of PD [Table 1 and Figure 1]
               and new topics in GC.
   178   179   180   181   182   183   184   185   186   187   188